ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)
Clinical trial NCT05662345 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05662345
- Sponsor
- Menarini Silicon Biosystems, INC
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-12
- Primary completion
- 2025-11-14
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.